# Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI

> **NCT00242112** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 31 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** MRI Prostate

## Key facts

- **NCT ID:** NCT00242112
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242112, "Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00242112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*